Intco Medical Technology Co., Ltd. (SHE:300677)
China flag China · Delayed Price · Currency is CNY
49.42
+2.47 (5.26%)
Nov 17, 2026, 3:04 PM CST

Intco Medical Technology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
5,4325,94812,0147,2225,0335,003
Short-Term Investments
---723.211,613-
Trading Asset Securities
2,6187,2436,7375,2361,6243,274
Cash & Short-Term Investments
8,05013,19118,75113,1818,2708,277
Cash Growth
-63.96%-29.65%42.26%59.39%-0.09%29.52%
Accounts Receivable
1,6511,3711,379937.18555.36775.15
Other Receivables
38.1146.0878.3341.8980.9330.6
Receivables
1,6891,4171,457979.08636.29805.75
Inventory
1,9971,3271,2651,1501,0041,079
Other Current Assets
435.83363.99480.62292.93325.23600.95
Total Current Assets
12,17116,29921,95515,60310,23510,763
Property, Plant & Equipment
11,65611,6079,7909,2468,9118,262
Long-Term Investments
15,53110,4611,382970.38884.94473.89
Other Intangible Assets
732.6729.1767.03566.84583.48629.91
Long-Term Deferred Tax Assets
58.8651.6180.3564.0988.3177.23
Long-Term Deferred Charges
4.694.925.221.841.762.9
Other Long-Term Assets
893.74937.67651.63627.32774.31415.84
Total Assets
41,04840,09034,63127,07921,47920,625

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
1,6351,257845.38921.6946.361,238
Accrued Expenses
139234.47215.38174.47201.53194
Short-Term Debt
17,21916,39012,6667,0341,49450.48
Current Portion of Long-Term Debt
318.66701.44436.3753.429.0434.29
Current Portion of Leases
---1.944.012.64
Current Income Taxes Payable
338.59116.4165.1815.649.6337.5
Current Unearned Revenue
213.26237271.58293.6300.89414.16
Other Current Liabilities
323.28241.9182.41123.67169.43113.07
Total Current Liabilities
20,18719,17814,6838,6183,1552,084
Long-Term Debt
222.8409.29166.877.2551.59201.26
Long-Term Leases
----1.783.38
Long-Term Unearned Revenue
206.94211.99155.84123.99128.53201.02
Long-Term Deferred Tax Liabilities
1,7291,7191,9441,9652,0932,012
Total Liabilities
22,34521,51916,94910,7855,4294,501

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
654.75654.75646.19656659.55549.58
Additional Paid-In Capital
1,2271,1831,1141,2871,3101,509
Retained Earnings
16,77416,69215,77814,39614,07213,855
Treasury Stock
-239.12-239.12-133.47-320.55-253.81-27.76
Comprehensive Income & Other
-109.59-36.68-0.3810.6318.79-15.22
Total Common Equity
18,30718,25417,40416,02915,80615,871
Minority Interest
395.12318.06277.6265.99242.93252.25
Shareholders' Equity
18,70218,57217,68216,29516,04916,123
Total Liabilities & Equity
41,04840,09034,63127,07921,47920,625

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
17,76017,50113,2697,1661,580292.05
Net Cash (Debt)
-9,710-4,3105,4826,0156,6897,985
Net Cash Growth
---8.86%-10.08%-16.23%30.68%
Net Cash Per Share
-14.99-6.698.459.1110.1011.82
Filing Date Shares Outstanding
650.3646.16641.39643.38659.55659.49
Total Common Shares Outstanding
650.3646.16641.39643.38659.55659.49
Working Capital
-8,016-2,8797,2726,9857,0808,679
Book Value Per Share
28.1528.2527.1424.9123.9724.07
Tangible Book Value
17,57517,52516,63715,46215,22315,241
Tangible Book Value Per Share
27.0327.1225.9424.0323.0823.11
Land
-11.7211.7211.7211.5210.55
Buildings
-5,8874,5574,0573,4802,400
Machinery
-8,4716,6245,6134,9864,247
Construction In Progress
-803.111,2881,5091,7052,326